Shares of Equinox Gold Corp (CVE:EQX – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight research firms that are covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is C$9.76.
A number of research firms recently weighed in on EQX. Haywood Securities lowered their price objective on shares of Equinox Gold from C$12.75 to C$11.50 in a research report on Friday, August 9th. Scotiabank lifted their price objective on shares of Equinox Gold from C$8.50 to C$8.75 in a research report on Thursday, November 21st. Royal Bank of Canada lowered their price objective on shares of Equinox Gold from C$11.00 to C$10.00 in a research report on Monday, October 21st. Finally, CIBC lowered their price objective on shares of Equinox Gold from C$9.50 to C$8.80 in a research report on Friday, October 4th.
View Our Latest Stock Report on EQX
Equinox Gold Stock Performance
Insiders Place Their Bets
In other news, Senior Officer Gordana Vicentijevic sold 7,000 shares of Equinox Gold stock in a transaction on Monday, November 18th. The stock was sold at an average price of C$7.67, for a total transaction of C$53,690.00.
About Equinox Gold
Equinox Gold Corp. engages in the acquisition, exploration, and development of mineral deposits. The company's principal properties include the Aurizona project covering a total land package of approximately 223,160 hectares located in Maranhão State, Brazil; and the Castle Mountain property situated in California, the United States.
Further Reading
- Five stocks we like better than Equinox Gold
- What is a SEC Filing?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is the S&P 500 and How It is Distinct from Other Indexes
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Use the MarketBeat Dividend Calculator
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Equinox Gold Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equinox Gold and related companies with MarketBeat.com's FREE daily email newsletter.